Threshold Pharmaceuticals, Inc., based in South San Francisco,
California, is a research-driven biotechnology company dedicated to the discovery and development of tumor targeted therapies to improve the lives of patients with cancer.
- March 19, 2015
- Threshold Pharmaceuticals to Present Data Supporting Planned Phase 2 Trials of TH-4000, a Hypoxia-Activated, Irreversible EGFR Tyrosine Kinase Inhibitor
- March 3, 2015
- Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial and Operational Results
- February 24, 2015
- Threshold Pharmaceuticals Announces Presentation and Webcast at the 2015 Cowen Health Care Conference